NCT05327894 2026-04-13Interfant-21Princess Maxima Center for Pediatric OncologyPhase 3 Recruiting160 enrolled
NCT03959085 2026-03-31Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLyChildren's Oncology GroupPhase 3 Recruiting5,951 enrolled
NCT05602194 2026-03-12Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or LymphomaChildren's Oncology GroupPhase 3 Recruiting440 enrolled